TNF-α (-308 G/A) and CD14 (-159T/C) polymorphisms in the bronchial responsiveness of Korean children with asthma

Journal of Allergy and Clinical Immunology

Volumn 119, Issue 2, 2007, Pages 398-404

  Hong, Soo Jong ^a   Kim, Hyo Bin ^a   Kang, Mi Jin ^b   Lee, So Yeon ^c   Kim, Ja Hyung ^a   Kim, Bong Seong ^a   Jang, Seong Ok ^b   Shin, Hyung Doo ^d   Park, Choon Sik ^e  

^a University of Ulsan College of Medicine   (South Korea)

^b University of Ulsan   (South Korea)

^c Hallym University College of Medicine   (South Korea)

^d SNP Genetics Inc   (South Korea)

^e Soonchunhyang University   (South Korea)

Author keywords

asthma; atopy; bronchial hyperreactivity; CD14; polymorphism; Tumor necrosis factor

Indexed keywords

CD14 ANTIGEN; METHACHOLINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; EVALUATION; EXERCISE; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; KOREA; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ALLELES; ANTIGENS, CD14; ASTHMA; BRONCHIAL HYPERREACTIVITY; CHILD; FEMALE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846821973     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.10.031     Document Type: Article

References (50)

1. Kay A.B. Allergy and allergic disease. First of two parts. N Engl J Med 344 (2001) 30-37
2. Busse W.W., Banks-Schlegel S., and Wenzel S.E. Pathophysiology of severe asthma. J Allergy Clin Immunol 106 (2000) 1033-1042
3. British Thoracic Society. Scottish Intercollegiate Guidelines Network (SIGN). British guidelines on the management of asthma. Thorax 58 suppl 1 (2003) 1-94
4. Kips J.C., Tavernier J., and Pauwels R.A. Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am Rev Respir Dis 145 (1992) 332-336
5. Thomas P.S., Yates D.H., and Barnes P.J. Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med 152 (1995) 76-80
6. Thomas P.S., and Heywood G. Effects of inhaled tumor necrosis factor alpha in subjects with mild asthma. Thorax 57 (2002) 774-778
7. Howarth P.H., Babu K.S., Arshad H.S., Lau L., Buckley M., McConnell W., et al. Tumor necrosis factor (TNFα) as a novel therapeutic target in symptomatic corticosteroid-dependent asthma. Thorax 60 (2005) 1012-1018
8. Gao J., Shan G., Sun B., Thompson P.J., and Gao X. Association between polymorphism of tumour necrosis factor α -308 gene promoter and asthma: a meta-analysis. Thorax 61 (2006) 466-471
9. Daniels S.E., Bhattacharrya S., James A., Leaves N.I., Young A., Hill M.R., et al. A genome-wide search for quantitative trait loci underlying asthma. Nature 383 (1996) 247-250
10. Xu J., Meyers D.A., Ober C., Blumenthal M.N., Mellen B., Barnes K.C., et al. Genomewide screen and identification of gene-gene interactions for asthma-susceptibility loci in three U.S. populations: collaborative study on the genetics of asthma. Am J Hum Genet 68 (2001) 1437-1446
11. Berry M.A., Hargadon B., Shelley M., Parker D., Shaw D.E., Green R.H., et al. Evidence of a role of tumor necrosis factor α in refractory asthma. N Engl J Med 354 (2006) 697-708
12. Li Kam Wa T.C., Mansur A.H., Britton J., Williams G., Pavord I., Richards K., et al. Association between -308 tumour necrosis factor promoter polymorphism and bronchial hyperreactivity in asthma. Clin Exp Allergy 29 (1999) 1204-1208
13. Noguchi E., Yokouchi Y., Shibasaki M., Inudou M., Nakahara S., Nogami T., et al. Association between TNFA polymorphism and the development of asthma in the Japanese population. Am J Respir Crit Care Med 166 (2002) 43-46
14. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., and Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94 (1997) 3195-3199
15. Louis E., Franchimont D., Piron A., Gevaert Y., Schaaf-Lafontaine N., Roland S., et al. Tumor necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 113 (1998) 401-406
16. Mofatt M.F., and Cookson W.O. Tumour necrosis factor haplotypes and asthma. Hum Mol Genet 6 (1997) 551-554
17. Chagai T., Pare P.D., Zhu S., Weir T.D., Bai T.R., Behbehani N.A., et al. Prevalence of tumor necrosis factor-α and angiotensin converting enzyme polymorphisms in mild/moderate and fatal/near-fatal asthma. Am J Respir Crit Care Med 160 (1999) 278-282
18. Moffatt M.F., James A., Ryan G., Musk A.W., and Cookson W.O. Extended tumour necrosis factor/HLA-DR haplotypes and asthma in an Australian population sample. Thorax 54 (1999) 757-761
19. Winchester E.C., Milwood I.Y., Rand L., Penny M.A., and Kessling A.M. Association of the TNF-α -308(G→A) polymorphism with self-reported history of childhood asthma. Hum Genet 107 (2000) 591-596
20. Witte J.S., Palmer L.J., O'Connor R.D., Hopkins P.J., and Hall J.M. Relation between tumor necrosis factor polymorphism TNF alpha -308 and risk of asthma. Eur J Hum Genet 10 (2002) 82-85
21. Wang T.N., Chen W.Y., Wang T.H., Chen C.J., Huang L.Y., and Ko Y.C. Gene-gene synergistic effect on atopic asthma: tumor necrosis factor-alpha -308 and lymphotoxin-alpha-NcoI in Taiwan's children. Clin Exp Allergy 34 (2004) 184-188
22. Li Kam Wa T.C., Mansur A.H., Britton J., Williams G., Pavord I., Richards K., et al. Association between-308 tumour necrosis factor promoter necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci U S A 173 (1997) 209-219
23. Buckova D., Holla L.I., Vasku A., Znojil V., and Vacha J. Lack of association between atopic asthma and the tumor necrosis factor alpha -308 gene polymorphism in Czech population. J Investig Allergol Clin Immunol 12 (2002) 192-197
24. Di Somma C., Charron D., Deichmann K., Buono C., and Ruffilli A. Atopic asthma and TNF-308 alleles: linkage disequilibrium and association analyses. Hum Immunol 64 (2003) 359-365
25. El Bahlawan L., Christensen M., Binaei S., Murphy C., Zhang Q., and Quasney M. Lack of association between the tumor necrosis factor-alpha regulatory region genetic polymorphisms associated with elevated tumor necrosis factor-alpha levels and children with asthma. Chest 123 suppl (2003) 374S-375S
26. Lin Y.C., Lu C.C., Su H.J., Shen C.Y., Lei H.Y., and Guo Y.L. The association between tumor necrosis factor, HLA-DR alleles, and IgE-mediated asthma in Taiwanese adolescents. Allergy 57 (2002) 831-834
27. Louis R., Leyder E., Malaise M., Bartsch P., and Louis E. Lack of association between adult asthma and the tumor necrosis factor alpha-308 polymorphism gene. Eur Respir J 16 (2000) 604-608
28. Albuquerque R.V., Hayden C.M., Palmer L.J., Laing I.A., Rye P.J., Gibson N.A., et al. Association of polymorphisms within the tumor necrosis factor (TNF) genes and childhood asthma. Clin Exp Allergy 28 (1997) 578-584
29. Shin H.D., Park B.L., Kim L.H., Jung J.H., Wang J.H., Kim Y.J., et al. Association of tumor necrosis factor polymorphisms with asthma and serum total IgE. Hum Mol Genet 13 (2004) 397-403
30. Randolph A.G., Lange C., Silverman E.K., Lazarus R., and Weiss S.T. Extended haplotype in the TNF gene cluster is associated with asthma and asthma related phenotypes. Am J Respir Crit Care Med 172 (2005) 687-692
31. Baldini M., Lohman I.C., Halonen M., Erickson R.P., Holt P.G., Martinez F.D., et al. A polymorphism in the 5′flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 20 (1999) 976-983
32. Koppelman G.H., Reijmerink N.E., Colin Stine O., Howard T.D., Whittaker P.A., Meyers D.A., et al. Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med 163 (2001) 965-969
33. Gao P.S., Mao X.Q., Baldini M., Roberts M.H., Adra C.N., Shirakawa T., et al. Serum total IgE levels and CD14 on chromosome 5q31. Clin Genet 56 (1999) 164-165
34. Vercelli D. The functional genomics of CD14 and its role in IgE responses: an integrated view. J Allergy Clin Immunol 109 (2002) 14-21
35. Landmann R., Muller B., and Zimmerli W. CD14, new aspects of ligand and signal diversity. Microbes Infect 2 (2000) 295-304
36. Dobrovolskaia M.A., and Vogel S.N. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 4 (2002) 903-914
37. Ziegler-Heitbrock H.W.L., and Ulevitch R.J. CD14: cell surface receptor and differentiation marker. Immunol Today 14 (1993) 121-125
38. Koppelman G.H., Meijer G.G., Bleecker E.R., and Postma D.S. Genetics of asthma. In: Clark T.J.H., Godfrey S., Lee T.H., and Thomson N.C. (Eds). Asthma (2000), Arnold, London 146-174
39. Sengler C., Haider A., Sommerfeld C., Lau S., Baldini M., Martinez F.D., et al. Evaluation of the CD14 C159T polymorphism in the German Multicenter Allergy Study cohort. Clin Exp Allergy 33 (2003) 166-169
40. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136 (1987) 225-244
41. Lee S.G., Kim B.S., Kim J.H., Lee S.Y., Choi S.O., Shim J.Y., et al. Gene-gene interaction between interleukin-4 and interleukin-4 receptor α in Korean children with asthma. Clin Exp Allergy 34 (2004) 1202-1208
42. Chai H., Farr R.S., Froehlich L.A., Mathison D.A., McLean J.A., Rosenthal R.R., et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 56 (1975) 323-327
43. Kim H.B., Lee S.Y., Shim J.Y., Kim J.H., Kang M.J., and Hong S.J. The LTC4S (A-444C) promoter polymorphisms is associated with the severity of exercise-induced asthma in Korean children. J Allergy Clin Immunol 117 (2006) 1191-1192
44. Winchester E.C., Millwood I.Y., Rand L., Penny M.A., and Kessling A.M. Association of the TNF-alpha-308(G→A) polymorphism with self-reported history of childhood asthma. Hum Genet 107 (2000) 591-596
45. *1, allele frequency in Spanish atopic patients. J Invest Allergol Clin Immunol 10 (2000) 149-154
46. Ulbrich H., Eriksson E.E., and Lindbom L. Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends Pharmacol Sci 24 (2003) 640-647
47. Ming W.J., Bersani L., and Mantovani A. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol 138 (1987) 1469-1474
48. Knight J.C., Keating B.J., Rockett K.A., and Kwiatkowski D.P. In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat Genet 33 (2003) 469-475
49. Schutt C., Schilling T., Grunwald U., Schonfeld W., and Kruger C. Endotoxin-neutralizing capacity of soluble CD14. Res Immunol 143 (1992) 71-78
50. Manogue K.R., Van Deventer S.J.H., and Cerami A. Tumor necrosis factor alpha or cachectin. In: Thomson A.W. (Ed). The cytokine handbook (1991), Academic Press, London 241-256